BFM
SPRB

Boothbay Fund Management’s Spruce Biosciences SPRB Stock Holding History

Boothbay Fund Management’s Portfolio SPRB Stock Details SPRB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$2.75M Sell
42,080
-5,853
-12% -$404K 0.04% 500
2025
Q4 		$4.18M Buy
+47,933
New +$5.14M 0.06% 340
2025
Q2 		– Sell
-3,851
Closed -$83.8K – 1852
2025
Q1 		$83.8K Hold
3,851
– – ﹤0.01% 1239
2024
Q4 		$121K Buy
+3,851
New +$141K ﹤0.01% 1259

Other funds holding SPRB

IC
Ikarian Capital Dallas, Texas $928M AUM 596.14% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return
ACM
ADAR1 Capital Management Austin, Texas $2.19B AUM 374.99% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $80.2B AUM 51.53% 1-Year Est. Return
CG
Carlyle Group Washington, District of Columbia $10B AUM 10.61% 1-Year Est. Return
QOP
Quinn Opportunity Partners Charlottesville, Virginia $2.16B AUM 28.56% 1-Year Est. Return
ECM
ExodusPoint Capital Management New York $15.5B AUM 38.81% 1-Year Est. Return

Boothbay Fund Management's SPRB Position: Q1 2026 in Review

Boothbay Fund Management reduced its Spruce Biosciences (SPRB) stake by 12% in Q1 2026, selling an estimated $404K and leaving 42,080 shares worth $2.75M. The position accounts for 0.04% of the portfolio, ranked #500.

Boothbay Fund Management first reported a position in SPRB in Q4 2024 and has held it in 4 quarters since. The position peaked at $4.18M in Q4 2025. 32 funds tracked by Wall St. Rank hold SPRB as of Q1 2026.

  • Boothbay Fund Management held 42,080 shares of Spruce Biosciences worth $2.75M as of Q1 2026.
  • Boothbay Fund Management sold 5,853 Spruce Biosciences shares in Q1 2026, an estimated $404K.
  • Spruce Biosciences made up 0.04% of Boothbay Fund Management's portfolio in Q1 2026, its #500 holding.
  • Boothbay Fund Management first reported a position in Spruce Biosciences in Q4 2024 and has held it in 4 quarters since.
  • Boothbay Fund Management's Spruce Biosciences position peaked at $4.18M in Q4 2025.
  • 32 funds tracked by Wall St. Rank held Spruce Biosciences as of Q1 2026.

Based on Boothbay Fund Management's 13F filing for Q1 2026, filed 15 May 2026.